Literature DB >> 8016095

The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.

A F Voronova1, F Lee.   

Abstract

The immunoglobulin enhancer-binding proteins, E12 and E47, encoded by the E2A gene belong to the basic helix-loop-helix (bHLH) family of regulatory proteins and act as transcriptional activators. In addition to their critical role in B-lymphocyte development, the E12 and E47 proteins have been implicated in the induction of myogenesis as heterodimeric partners of myogenic bHLH proteins, MyoD and myogenin. Here we demonstrate that the E2A proteins form heterodimers with the bHLH oncoprotein tal-1 in myeloid and erythroid cells and that these heterodimers specifically bind to the CANNTG DNA motif. Heterodimerization with tal-1 represses transactivation by E47 and could function to prevent the expression of immunoglobulin genes in cells other than B lymphocytes. DNA binding by E2A-tal-1 heterodimers in the M1 mouse myeloid cell line is abrogated upon terminal macrophage differentiation induced by the cytokine interleukin 6. The loss of E2A-tal-1 DNA binding is correlated with elevated expression of mRNA encoding the dominant negative HLH proteins, Id1 and particularly Id2. Moreover, recombinant Id proteins inhibit the E2A-tal-1-specific DNA binding activity from undifferentiated M1 cells. These results suggest that E2A-tal-1 heterodimers may play a role in preventing terminal differentiation in the myeloid lineage and provide a possible explanation for oncogenic transformation induced by ectopic tal-1 expression in acute T-cell lymphoblastic leukemias.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016095      PMCID: PMC44115          DOI: 10.1073/pnas.91.13.5952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  The protein Id: a negative regulator of helix-loop-helix DNA binding proteins.

Authors:  R Benezra; R L Davis; D Lockshon; D L Turner; H Weintraub
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

2.  MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer.

Authors:  A B Lassar; J N Buskin; D Lockshon; R L Davis; S Apone; S D Hauschka; H Weintraub
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

3.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

5.  IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.

Authors:  C P Chiu; F Lee
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

6.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.

Authors:  C G Begley; P D Aplan; S M Denning; B F Haynes; T A Waldmann; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Expression of tal-1 and GATA-binding proteins during human hematopoiesis.

Authors:  M A Mouthon; O Bernard; M T Mitjavila; P H Romeo; W Vainchenker; D Mathieu-Mahul
Journal:  Blood       Date:  1993-02-01       Impact factor: 22.113

10.  Chromosomal translocation involving the beta T cell receptor gene in acute leukemia.

Authors:  M L Cleary; J D Mellentin; J Spies; S D Smith
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  28 in total

1.  Fetal Alz-50 clone 1, a novel zinc finger protein, binds a specific DNA sequence and acts as a transcriptional regulator.

Authors:  K L Jordan-Sciutto; J M Dragich; J L Rhodes; R Bowser
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

2.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.

Authors:  J Wang; S N Jani-Sait; E A Escalon; A J Carroll; P J de Jong; I R Kirsch; P D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

3.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

4.  Repression of Id2 expression by Gfi-1 is required for B-cell and myeloid development.

Authors:  Huajie Li; Ming Ji; Kimberly D Klarmann; Jonathan R Keller
Journal:  Blood       Date:  2010-05-07       Impact factor: 22.113

5.  Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins.

Authors:  Ming Ji; Huajie Li; Hyung Chan Suh; Kimberly D Klarmann; Yoshifumi Yokota; Jonathan R Keller
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

6.  Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.

Authors:  A Lasorella; A Iavarone; M A Israel
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Induction of basic helix-loop-helix protein-containing complexes during erythroid differentiation.

Authors:  J A Lister; M H Baron
Journal:  Gene Expr       Date:  1998

8.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

9.  OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.

Authors:  Ying-Wei Lin; Ramona Deveney; Mary Barbara; Norman N Iscove; Stephen D Nimer; Christopher Slape; Peter D Aplan
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

10.  Disruption of pre-TCR expression accelerates lymphomagenesis in E2A-deficient mice.

Authors:  Isaac Engel; Cornelis Murre
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.